ULTRAGENYX PHARMACEUTICAL IN's ticker is and the CUSIP is 90400D908. A total of 4 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $563,270 | -55.1% | 15,800 | -41.9% | 0.00% | – |
| Q2 2023 | $1,254,736 | -8.0% | 27,200 | -20.0% | 0.00% | -100.0% |
| Q1 2023 | $1,363,400 | -64.4% | 34,000 | -58.8% | 0.00% | -50.0% |
| Q4 2022 | $3,826,858 | +200.1% | 82,600 | +168.2% | 0.00% | +100.0% |
| Q3 2022 | $1,275,000 | +250.3% | 30,800 | +404.9% | 0.00% | – |
| Q2 2022 | $364,000 | – | 6,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 46,700 | $1,664 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,600 | $57,040 | 0.00% |
| JANE STREET GROUP, LLC | 15,800 | $563,270 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |